The anti‐inflammatory effect of metformin: The molecular targets.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 183, doi. 10.1111/gtc.13098
- By:
- Publication type:
- Article
Works matching IS 13569597 AND DT 2024 AND VI 29 AND IP 3
Results: 7
1
2
Mouse transient receptor potential melastatin 2 (TRPM2) isoform 7 attenuates full‐length mouse TRPM2 activity through reductions in its expression by targeting it to ER‐associated degradation.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 254, doi. 10.1111/gtc.13097
- By:
- Publication type:
- Article
3
The optimized priming effect of FGF‐1 and FGF‐2 enhances preadipocyte lineage commitment in human adipose‐derived mesenchymal stem cells.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 231, doi. 10.1111/gtc.13095
- By:
- Publication type:
- Article
4
GTP‐dependent regulation of heterochromatin fluctuations at subtelomeric regions in Saccharomyces cerevisiae.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 217, doi. 10.1111/gtc.13094
- By:
- Publication type:
- Article
5
Extracellular α‐synuclein impairs sphingosine 1‐phosphate receptor type 3 (S1PR3)‐regulated lysosomal delivery of cathepsin D in HeLa cells.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 207, doi. 10.1111/gtc.13093
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 179, doi. 10.1111/gtc.13039
- Publication type:
- Article
7
Transcriptional features of low‐grade neuroepithelial tumors with the BRAF V600E mutation associated with epileptogenicity.
- Published in:
- Genes to Cells, 2024, v. 29, n. 3, p. 192, doi. 10.1111/gtc.13096
- By:
- Publication type:
- Article